RALLYBIO CORP (RLYB:NASDAQ)
$8.3 -0.14 (-1.6588%)
Analysed RALLYBIO CORP (RLYB:NASDAQ) News Sources
Rallybio to acquire Candid Therapeutics
03-03-2026
pharmaceutical-technology.com
Rallybio Corporation and Candid Therapeutics Announce Merger Agreement
02-03-2026
yahoo.com
Candid, in a reverse merger with RallyBio, to go public
02-03-2026
biopharmadive.com
Rallybio Announces Positive Data for RLYB116 Phase 1 Study Demonstrating Complete and Sustained Inhibition of Terminal Complement
17-02-2026
yahoo.com
Stock Splits Matter: What’s Coming Up This Month?
04-02-2026
247wallst.com
Rallybio Announces Reverse Stock Split of Common Stock
03-02-2026
yahoo.com
Rallybio Reports Third Quarter 2025 Financial Results and Provides Business Updates
06-11-2025
yahoo.com
Does Short Squeeze Attention and AI Advances Alter the Bull Case for Recursion Pharmaceuticals (RXRX)?
27-09-2025
yahoo.com
Rallybio Completes Dosing of First Cohort in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study
25-09-2025
yahoo.com
Recursion Pharmaceuticals, Inc. (RXRX) Secures $12.5M Milestone From Rallybio as REV102 Advances
21-09-2025
yahoo.com
What is the current price of RALLYBIO CORP (RLYB:NASDAQ)?
The current price of RALLYBIO CORP (RLYB:NASDAQ) is $8.3.
RALLYBIO CORP (RLYB:NASDAQ) absolute price change since previous trading day?
The absolute price change of RALLYBIO CORP (RLYB:NASDAQ) since the previous trading day is $-0.14.
RALLYBIO CORP (RLYB:NASDAQ) percentage price change since previous trading day?
The percentage price change of RALLYBIO CORP (RLYB:NASDAQ) since the previous trading day is -1.6588%.
What is the most recent average sentiment score for RALLYBIO CORP (RLYB:NASDAQ)?
The most recent average sentiment score for RALLYBIO CORP (RLYB:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for RALLYBIO CORP (RLYB:NASDAQ)?
The most recent sentiment for RALLYBIO CORP (RLYB:NASDAQ) is .
SEC-8K** Filing Available For RALLYBIO CORP (RLYB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.